Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
| ▸ | MDK | P21741 | 3/20 | 0.43 |
| ▸ | BDNF | P23560 | 3/20 | 0.43 |
| ▸ | PTN | P21246 | 2/20 | 0.43 |
| ▸ | CD69 | Q07108 | 1/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.41 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12952583 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL15274904 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL12213976 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL15215584 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL18254178 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL25121361 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL15082697 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL4544701 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL21374694 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK | |
| SCHEMBL10157433 | 1.00 | MAPK1 (0.44) | MAPK1LGALS3LGALS8LGALS4MDK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218500-A1 | SKIN EXTERNAL COMPOSITION COMPRISING CROSSLINKED HYALURONIC ACID GEL | AMOREPACIFIC CORPORATION (KR) | 2023-07-13 | — | — | US | disclosed |
| US-20230133656-A1 | HYDROGEL COMPOSITIONS AND USES THEREOF | SHOICHET, MOLLY SANDRA (CA) | 2023-05-04 | — | — | US | disclosed |
| US-11173106-B2 | Compositions comprising a superhydrophilic amphiphilic copolymer and a micellar thickener | JOHNSON & JOHNSON CONSUMER INC. (US) | 2021-11-16 | — | — | US | disclosed |
| US-9937118-B2 | Clear suspending personal care cleansing compositions | JOHNSON & JOHNSON CONSUMER INC. (US) | 2018-04-10 | — | — | US | disclosed |
| US-20170360680-A1 | CLEAR SUSPENDING PERSONAL CARE CLEANSING COMPOSITIONS | KENVUE BRANDS LLC | 2017-12-21 | — | — | US | disclosed |
| US-20170202982-A1 | Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith | WAKE FOREST UNIVERSITY | 2017-07-20 | — | — | US | disclosed |
| US-20170079893-A1 | PHASE-STABLE SUNSCREEN COMPOSITIONS COMPRISING AN ULTRAVIOLET RADIATION-ABSORBING COMPOUND AND SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS | JOHNSON & JOHNSON CONSUMER INC. | 2017-03-23 | — | — | US | disclosed |
| US-20120316099-A1 | COMPOSITIONS COMPRISING SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS AND METHODS OF USE THEREOF | KENVUE BRANDS LLC | 2012-12-13 | — | — | US | disclosed |
| US-8258250-B2 | Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-20110082105-A1 | COMPOSITIONS COMPRISING SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS AND METHODS OF USE THEREOF | KENVUE BRANDS LLC | 2011-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133656-A1 | HYDROGEL COMPOSITIONS AND USES THEREOF | CD44, UACA, ALDH1A2 | MAPK1 3667/4885LGALS3 78/4885LGALS8 381/4885 |
| US-20170079893-A1 | PHASE-STABLE SUNSCREEN COMPOSITIONS COMPRISING AN ULTRAVIOLET RADIATION-ABSORBING COMPOUND AND SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS | PCNA, MMS19, SUN2 | MAPK1 4401/4885LGALS3 4450/4885LGALS8 4434/4885 |
| US-20170202982-A1 | Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith | CD44, HLA-A, HLA-C | MAPK1 2043/4885LGALS3 15/4885LGALS8 24/4885 |
| US-20110082105-A1 | COMPOSITIONS COMPRISING SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS AND METHODS OF USE THEREOF | PHOSPHO1, LIPA, ABHD16A | MAPK1 4875/4885LGALS3 1251/4885LGALS8 1607/4885 |
| US-20230218500-A1 | SKIN EXTERNAL COMPOSITION COMPRISING CROSSLINKED HYALURONIC ACID GEL | DSG1, H1-0, CD44 | MAPK1 2375/4885LGALS3 1898/4885LGALS8 142/4885 |
| US-20170360680-A1 | CLEAR SUSPENDING PERSONAL CARE CLEANSING COMPOSITIONS | DSG1, CUTA, SNU13 | MAPK1 3782/4885LGALS3 1365/4885LGALS8 2170/4885 |
| US-11173106-B2 | Compositions comprising a superhydrophilic amphiphilic copolymer and a micellar thickener | ABHD16A, DSG1, CUTA | MAPK1 4623/4885LGALS3 1153/4885LGALS8 1224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.